首页|肿瘤间质比和肿瘤间质浸润淋巴细胞对HER2阴性乳腺癌新辅助治疗疗效的影响

肿瘤间质比和肿瘤间质浸润淋巴细胞对HER2阴性乳腺癌新辅助治疗疗效的影响

扫码查看
目的 探讨肿瘤间质比(tumor-stroma ratio,TSR)和肿瘤间质浸润淋巴细胞(stromal tumor-infiltrating lymphocytes,sTILs)对HER2阴性乳腺癌新辅助治疗(neoadjuvant therapy,NAT)疗效的预测意义.方法 收集516例术前穿刺确诊为HER2阴性乳腺浸润性癌患者,均接受NAT后进行根治性手术.评估常规HE切片中TSR和sTILs的状态,术后标本进行残余肿瘤负荷(residual cancer burden,RCB)分级、Miller-Payne(MP)分级、病理完全缓解(pathological complete response,pCR)评估.采用Pearson x2和趋势x2检验观察TSR、sTILs、TSR联合sTILs与临床病理特征的关系;应用Logistic二元回归分析TSR、sTILs、TSR联合sTILs与pCR率的关系.结果 516例乳腺癌中高TSR(间质占比≤50%)者278例(53.9%),低TSR(间质占比>50%)者238例(46.1%).NAT前高TSR组和高sTILs组的肿瘤与较高的MP分级、较低的RCB分级显著相关,pCR率高(P<0.05).术前活检高TSR患者pCR的概率比低TSR患者高2.163倍(OR:2.163,95%CI:1.201~3.898,P=0.010).激素受体(hormone receptor,HR)阴性组、高 TSR 对 NAT 后患者 pCR 率的 OR值为 2.999(95%CI:1.216~7.396,P=0.017).高 TSR、高 sTILs 组患者 NAT 后 pCR 率是低 TSR、低 sTILs 患者的 4.052 倍(OR:4.052,95%CI:1.900~8.644,P<0.001),差异均有统计学意义.结论 HER2阴性乳腺癌患者治疗前活检中较高的TSR和sTILs状态与NAT后较高的MP分级和较低的RCB分级、较高的pCR率相关,术前联合评估两者可为临床治疗提供帮助.
Effect of tumor-stroma ratio and stromal tumor-infiltrating lymphocytes on the efficacy of neoadjuvant therapy for HER2-negative breast cancer
Purpose To investigate the predictive signifi-cance of tumor-stroma ratio(TSR)and stromal tumor-infiltrating lymphocytes(sTILs)in neoadjuvant therapy(NAT)for HER2-negative breast cancer.Methods A total of 516 patients with HER2-negative invasive breast cancer by preoperative puncture were collected,and all of them underwent radical surgery after receiving NAT.TSR and sTILs in breast cancer tissue were eval-uated on routine HE sections of biopsy,and residual cancer bur-den(RCB)grading,Miller-Payne(MP)grading and pathologi-cal complete response(pCR)assessment were carried out in postoperative specimens.Associations between the TSR,sTILs,TSR combined with sTILs and clinicopathological features were examined using Pearson's chi-square,and the relationships with chemotherapy response were analyzed by linear by linear associa-tion.Logistic binary regression analysis was used to analyze the association between TSR,sTILs,TSR combined with sTILs and pCR rate.Results Among the 516 cases of breast cancer,278 cases(53.9%)had a high TSR(tumor stromal area≤50%)and 238 cases(46.1%)had a low TSR(tumor stromal area>50%).Tumors in TSR-high groups and sTILs-high groups be-fore NAT were significantly associated with higher MP grade and lower RCB grade,as well as higher pCR rate(P<0.05).The probability of obtaining pCR in patients with high TSR in preop-erative biopsy was 2.163 times higher than that in patients with low TSR(OR:2.163,95%CI:1.201-3.898,P=0.010).In the hormone receptor(HR)-negative group,the OR value of pCR rate in patients with high TSR was 2.999(95%CI:1.216-7.396,P=0.017).The pCR rate after NAT in patients with TSR-high and sTILs-high groups was 4.052 times higher than that in patients with TSR-low and sTILs-low(OR:4.052,95%CI:1.900-8.644,P<0.001),and the difference was statis-tically significant.Conclusion Higher TSR and sTILs status in pretreatment biopsies of HER2-negative breast cancer patients are associated with higher MP grade,lower RCB grade and high-er pCR rate after NAT,and preoperative joint evaluation of both can provide some help for clinical treatment.

breast neoplasmHER2-negative breast cancerneoadjuvant therapytumor-stroma ratiostromal tumor-infiltra-ting lymphocytesresidual cancer burdenpathological complete response

张玲玲、张勐、李赛男、蔡丽静、韩丹丹、刘月平

展开 >

河北医科大学第四医院病理科,石家庄 050011

河北省乳腺癌分子医学重点实验室,石家庄 050011

河北医科大学第四医院乳腺中心,石家庄 050011

乳腺肿瘤 HER2阴性乳腺癌 新辅助治疗 肿瘤间质比 肿瘤间质浸润淋巴细胞 RCB分级 病理完全缓解

2024

临床与实验病理学杂志
安徽医科大学,中华医学会安徽分会

临床与实验病理学杂志

CSTPCD北大核心
影响因子:0.776
ISSN:1001-7399
年,卷(期):2024.40(11)